IGM Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
IGM Biosciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $16.36 per share as of 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2025-03-06
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $16.36.
- 2024-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $16.41.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $27.81.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $31.59.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-12-31 | $16.36 10-K · filed 2025-03-06 |
| 2024-09-30 | $16.41 10-Q · filed 2024-11-08 |
| 2023-12-31 | $27.81 10-K · filed 2025-03-06 |
| 2022-12-31 | $31.59 10-K · filed 2024-03-07 |
| 2021-12-31 | $40.41 10-K · filed 2023-03-30 |
| 2021-09-30 | $38.01 10-Q · filed 2021-11-04 |
| 2021-06-30 | $31.18 10-Q · filed 2021-08-09 |
| 2021-03-31 | $30.47 10-Q · filed 2021-05-06 |
| 2020-12-31 | $15.54 10-K · filed 2022-03-29 |
| 2020-09-30 | $14.60 10-Q · filed 2020-11-05 |
| 2020-06-30 | $13.95 10-Q · filed 2020-08-06 |
| 2020-03-31 | $11.75 10-Q · filed 2020-05-07 |
| 2019-12-31 | $3.36 10-K · filed 2021-03-30 |
| 2019-09-30 | $3.01 10-Q · filed 2019-11-07 |
| 2018-12-31 | $1.16 10-K · filed 2020-03-26 |